ImprimisRx Timolol-Dorzolamide-Latanoprost Ophthalmic Drops Recall: Subpotent Drug Risk
ImprimisRx recalls specific ophthalmic drops due to subpotent drug content. This may affect prescription eye drops with lot numbers 03132019@2 and 05102019@2. Contact for details.
Lower-risk recall
Subpotent Drug
Contact the company
What happened, in plain English
ImprimisRx is recalling prescription eye drops containing timolol, dorzolamide, and latanoprost that may have lower-than-stated drug potency. This could lead to ineffective treatment for glaucoma or other eye conditions. Read more at govinfonow.com/recall/38268-imprimisrx-timolol-dorzolamide-latanoprost-ophthalmic-drops-recall-subpotent-drug-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/38268-imprimisrx-timolol-dorzolamide-latanoprost-ophthalmic-drops-recall-subpotent-drug-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-1579-2019
Cite this page
“ImprimisRx Timolol-Dorzolamide-Latanoprost Ophthalmic Drops Recall: Subpotent Drug Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38268-imprimisrx-timolol-dorzolamide-latanoprost-ophthalmic-drops-recall-subpotent-drug-risk. Based on FDA recall #D-1579-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1579-2019%22&limit=1).
Why it’s dangerous
The drops may contain less active drug than labeled, reducing effectiveness for treating glaucoma. This could lead to uncontrolled eye pressure and vision damage over time.
Who’s affected
Prescription holders of these specific ophthalmic drops with lot numbers 03132019@2 or 05102019@2 are affected. Patients with glaucoma or similar eye conditions are most at risk.
How to tell if you have this one
Check the lot number on the bottle: 03132019@2 (expires 09/17/2019) or 05102019@2 (expires 11/02/2019). These are prescription-only eye drops sold by ImprimisRx NJ.
- Brand
ImprimisRx- Category
Drug
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
Nationwide within the United States
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-1578-2019 | Timolol-Latanoprost P-F (0.5/0.005%) ophthalmic drops, packaged in 5mL bottles, Rx only, ImprimisRX NJ 1705 Route 46 West, Suite 4, Ledgewood, NJ 07852 (844) 446-6979; Lot #:01252019@1, Exp. 07/21/2019; 03182019@7, Exp. 09/7/2019; 05092019@2, Exp. 11/2/2019 | 405 bottles |
| D-1579-2019 | Timolol- Dorzolamide- Latanoprost P-F (0.5/2.0/0.005%) ophthalmic drops, packaged in 5mL bottles, Rx only, ImprimisRx NJ 1705 Route 46 West, Suite 4, Ledgewood, NJ 07852 (844) 446-6979; Lot #: 03132019@2, Exp. 09/17/2019; 05102019@2, Exp. 11/02/2019 | 246 bottles |
What to do — step by step
Check Product Details
Look for the lot numbers 03132019@2 or 05102019@2 on the bottle label.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 9 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Do I need to stop using these drops?
The recall does not require immediate discontinuation; check the lot number and contact ImprimisRx if unsure.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1579-2019 (July 17, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1579-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.